BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 3  |  Page : 8578-8581 Full Version
Optimizing prescription practices : a cross-sectional insight into drug utilisation pattern at a tertiary care hospital in southern odisha
Int J Biol Med Res. 2026; 17(3): 8578-8581  |  DOI: 10.65048/ijbmr.2026.17.3.8578.1046
Rashmi Ranjan Bhadra¹, Padmaja Priyadarshini Kar², Aurobindo Samantray³
¹Post Graduate Trainee, Department of Pharmacology, MKCG Medical College, Berhampur, Odisha, India, ORCID ID - 0009000136909924
²Assistant Professor, Department of Pharmacology, MKCG Medical College, Berhampur, Odisha, India, ORCID ID - 0009000755987227
³Professor and Head, Department of Community Medicine, DRIEMS Institute Of Health Sciences And Hospital, Cuttack, Odisha, India,
ORCID ID - 0009000466648712
Correspondence Address :
Dr Rashmi Ranjan Bhadra,
Senior Resident, Department of Pharmacology
MKCG Medical College, Berhampur, PIN - 760004
ORCID ID - 0009000136909924 E-mail: rbhadra032@gmail.com
Received: March 3, 2026 Accepted: May 17, 2026 Published: July 3, 2026

Abstract
Background & Aim : Irrational prescription, a global problem, leads to ineffective and unsafe treatment, which causes exacerbation or prolongation of illness as well as distress and harm to the patient. The incidence of irrational prescribing practices cannot be reduced without critical intervention, which involves assessing their causes, and for this, the World Health Organization (WHO) has developed a set of core prescribing indicators. This study aimed to assess drug use patterns using the WHO core prescribing indicators in the outpatient department of the District Headquarters Hospital, Berhampur, Odisha. Methods :A Retrospective, hospital-based, cross-sectional study was conducted over a three-month period. Six hundred outpatient department (OPD)-based prescriptions were analyzed using the WHO core prescribing indicators. The study outcomes were expressed as numbers and percentages using descriptive statistics. Results : A total of 1638 no. of drugs were prescribed for 600 prescriptions, and the average number of prescribed drugs was 2.73. Similarly, 373 (62.16%) prescriptions contained antibiotics, and 161 (26.83%) prescriptions involved injections. The Percentage of drugs prescribed as generic and the percentage of drugs prescribed from the National List of Essential Medicines were 100% each. Conclusion : There was moderate compliance with the WHO prescribing indicators in our study. Although the percentage of drugs prescribed as generic and the percentage of drugs prescribed from the NLEM were as per the WHO-recommended values, the average number of drugs per prescription was higher than the WHO-recommended values. The study also revealed the over-prescribing of both antibiotics and injections.
Keywords
Antibiotics, Core Prescribing Indicators, Injections, National List of Essential Medicines, World Health Organization

Introduction

A prescription may be defined as a formal written directive issued by a registered medical practitioner to a pharmacist for the preparation and dispensing of specified medications intended for a patient. Rational prescribing is a fundamental component of clinical practice, ensuring that medicines are used safely, effectively, and economically.[1] The World Health Organization (WHO) defined rational use of drugs as patients receiving medications appropriate to their clinical needs, in doses that meet their own individual requirements, for an adequate period, and at the lowest cost to them and their community.[2] Despite substantial advances in pharmacotherapy and healthcare systems, irrational use of medicines remains a widespread global issue. It has been estimated that a significant proportion of medicines worldwide are prescribed, dispensed, or consumed inappropriately. Additionally, many patients do not utilize medicines correctly, while access to essential medications remains inadequate for large segments of the global population.[3]

Irrational prescribing practices constitute a serious public health concern, as they may lead to therapeutic failure, increased adverse drug reactions, prolonged illness, and avoidable healthcare expenditure.[4] Inappropriate medicine use also imposes a considerable burden on healthcare infrastructure, particularly in resource-limited environments. Common forms of irrational prescribing observed in hospital settings include excessive polypharmacy, inappropriate selection of antimicrobial agents, unnecessary use of injectable preparations, deviation from established treatment guidelines, incorrect dosing practices, and preference for brand-name prescribing instead of generic names.[5] In developing countries, irrational prescription practices are more pronounced due to limited healthcare resources, inadequate regulation, variable availability of essential medicines, and lack of periodic prescription audits. These issues compromise patient safety and adversely affect the quality and affordability of healthcare delivery.

         Irrational drug use practices may increase the burden of  drug-related morbidity, mortality, and overall treatment costs.[6] Polypharmacy, for instance, has been associated with an elevated risk of drug–drug interactions and adverse drug reactions, particularly among hospitalized patients.[7]  Similarly, excessive reliance on injectable medications may expose patients to avoidable risks, including injection-related complications and transmission of infections.[8]        

Generic prescribing reduces the likelihood of errors in prescribing and dispensing medications by utilizing a single approved name for each drug rather than multiple brand names. Although WHO strongly advocates generic prescribing as a strategy for promoting rational medicine use, brand-based prescribing continues to be prevalent in many clinical settings.[9] Nonadherence to essential medicine lists and clinical guidelines may further compromise therapeutic outcomes and economic efficiency.

Irrational medicine prescribing in hospital settings is influenced by multiple factors, including institutional policies, drug availability, healthcare system characteristics, accessibility of evidence-based resources, regulatory frameworks, and prescriber-related considerations.[10] To address irrational prescribing, WHO recommends periodic evaluation of prescription patterns using standardized indicators. The WHO core prescribing indicators provide an objective and reproducible method for assessing drug utilization patterns and identifying deviations from rational prescribing. These indicators include the average number of drugs per prescription, use of generic names, prescription of antibiotics and injections, and adherence to the National List of Essential Medicines (NLEM).[11]

Periodic assessment of prescription patterns using these indicators helps identify irrational trends, monitor prescribing behavior, and plan targeted interventions, such as prescriber education and policy modifications. Hospital-based prescription audits are an important tool for improving prescribing practices and promoting rational drug use.

Despite the availability of standard guidelines, published data on prescription practices at district-level tertiary care hospitals in southern Odisha are limited. Understanding local prescribing patterns is essential for addressing region-specific challenges and optimizing drug utilization.

Therefore, the present study was undertaken to evaluate the drug utilization pattern in the outpatient department of the district headquarters hospital at Berhampur, Odisha, using WHO prescribing indicators, and to assess selected secondary parameters of prescription completeness and quality.

Primary objective -

To evaluate the drug utilization pattern in outpatient prescriptions at a district headquarters hospital in southern Odisha using the WHO core prescribing indicators.

Secondary objective -

To assess selected indicators of prescription completeness and quality

Materials and Method

Study setting

The study was conducted at the District Headquarters Hospital in Berhampur, Ganjam.

Study duration

The study was carried out over a period of three months, from June 1 to August 31, 2024

Study population

The study population comprised outpatient prescriptions issued by all clinical departments during the study period.

Study design

This was a Retrospective hospital-based cross-sectional study.

Sampling method

A convenience consecutive sampling method was used.

Sample size

A total of 600 prescriptions were included in this study.

Study Outcomes

Primary outcome -

Prescribing practices were assessed using the WHO core prescribing indicators, including:

1) Average number of drugs per prescription

2) Percentage of drugs prescribed by generic name

3) Percentage of encounters with an antibiotic prescribed

4) Percentage of encounters with an injection prescribed

5) Percentage of drugs prescribed from the National List of Essential Medicines (NLEM)

Secondary outcome -

1) Percentage of prescriptions containing complete demographic details

2) Percentage of prescriptions containing a documented diagnosis

3) Percentage of prescriptions containing dose details

4) Percentage of prescriptions containing prescriber details

5) Percentage of illegible prescriptions

6) Percentage of prescriptions adhering to Standard Treatment Guidelines (STGs)

Statistical analysis

Data were entered into Microsoft Excel and analyzed using descriptive statistical methods. Study outcomes were expressed as numbers and percentages and presented using tables and charts.

Ethical considerations

The study protocol was approved by the Institutional Ethics Committee of MKCG Medical College, Berhampur (letter no. 1498/dt 27.12.23 of chairman IEC).

Results

WHO prescribing Indicators

A total of 600 outpatient prescriptions were collected from the District Headquarters Hospital (DHH), Berhampur, Ganjam, during the study period from 1st June 2024 to August 31, 2024. A total of 1638 no.of drugs were prescribed, and the number of drugs per prescription was 2.73, which was higher than the WHO-recommended reference value (1.6–1.8). Similarly, 373 (62.16%) prescriptions contained antibiotics, which was higher than the WHO reference range (20–26.8%); 161 (26.83%) prescriptions contained injections, which was slightly above the WHO-recommended range (13.4–24.1%). The Percentage of drugs prescribed as generic and the percentage of drugs prescribed from the NLEM were 100% each. (Table 1)

Table I. Indicating WHO prescribing Indicators

Prescribing Indicators assessed

Average/Percentage in our study

WHO Reference value

 

No. Of Drugs per prescription

2.73

1.6 - 1.8

Percentage of drugs prescribed as generic

100%

100%

Percentage of drugs prescribed from NLEM

100%

100%

Percentage  Of  prescriptions encountered with Antimicrobials

62.16%

 

20 - 26.8 %

Percentage  Of  prescriptions encountered with Injectables

26.83%

 

13.4 - 24.1%

* Data were analyzed using descriptive statistics and expressed as frequency and percentages

Secondary parameters of prescription quality

Other components analyzed for the completeness of prescriptions were demographic data, including patient name, age, and sex, which were present in all prescriptions (100%). Diagnosis was present in 86% of the prescriptions. The dose of the drugs was present in 94% of the cases. Prescriber details were documented in 96% of the prescriptions. Prescription legibility issues were noted in 12.5% of prescriptions. Of the prescriptions, 24% did not adhere to the applicable Standard Treatment Guidelines (STGs). (Figure 1)

Figure 1 - Assessing secondary parameters of prescription

* Data were analyzed using descriptive statistics and expressed as percentages

Discussion

The present study evaluated prescription practices in a tertiary care hospital using WHO core prescribing indicators, which measure the performance of healthcare providers in key dimensions related to the appropriate use of drugs.

In this study, the average number of drugs per prescription  was 2.73, which was higher than the WHO-recommended range. Although this value exceeded recommended standards, it was comparatively lower than findings reported in certain studies, such as Hazra et al. (3.2) ,Wang et al. (3.52), and Bimo et al. (3.8), but was higher compared to a study done by Rehan et al(2.4).[12,13,14,15] The elevated average number of medications per prescription observed in the present study may suggest a tendency toward polypharmacy, which may increase the probability of adverse drug reactions, drug–drug interactions, and reduced medication adherence. Additionally, prescriptions containing multiple drugs may complicate treatment regimens and increase the economic burden on patients.

A notable observation in this study was the high proportion of prescriptions containing antibiotics (62.16%), which substantially exceeds the WHO reference range. Similar trends have been reported in other studies, although with varying magnitudes. Hazra et al. documented antibiotic use in 72.8% of prescriptions, whereas Tripathy et al. reported a comparatively lower prevalence of 47.7%.[12,16] Excessive use of antibiotics raises concerns regarding the development of antimicrobial resistance, a major global public health challenge.  This is primarily due to the lack of adequate laboratory facilities for screening culture sensitivity and resistance testing, which hinders the selection of appropriate antibiotic therapies.This situation leads practitioners to prescribe broad-spectrum antibiotics to cover suspected bacterial infections.  Inadequate implementation of antibiotic stewardship policies and lack of institutional treatment protocols may further exacerbate this issue.

The use of injectable medications was observed in 26.83% of prescriptions, which is marginally higher than the WHO reference values. When compared with other studies, this prevalence was notably higher than that reported by Tripathy et al. (8%) but lower than findings from international studies conducted in South Ethiopia (38.1%) and Uganda (48%).[16,17,18]  Overuse of injections not only reduces compliance of the patient to treatment but also exposes patients to avoidable risks, such as blood-borne infections and Adverse Drug Reactions. Furthermore, unnecessary reliance on injections may reflect prescriber perceptions regarding rapid therapeutic effects or patient expectations.

An encouraging finding of this study was that 100% of drugs were prescribed by generic name, which is considerably higher than observations reported in several earlier studies. Chandelkar and Rataboli reported a negligible proportion of generic prescribing (0.05%), while Rehan et al. documented 1.5%. Hazra et al. and Tripathy et al. observed intermediate values of 46.2% and 68%, respectively.[12,15,16,19] Generic prescribing is considered a cornerstone of rational medicine use, as it promotes prescribing clarity, minimizes confusion arising from multiple brand names, and reduces the risk of dispensing errors. Moreover, generic medicines are typically more economical, thereby reducing financial burden on patients and improving treatment accessibility.            

Similarly, the percentage of drugs prescribed from the National List of Essential Medicines (NLEM) was 100%, indicating strong adherence to national prescribing policies. This finding is notably higher than that reported by Hazra et al., where only 45.71% of prescribed drugs were consistent with essential medicine recommendations.[12]Prescribing from essential medicine lists supports rational, evidence-based, and cost-effective therapy.

With regard to prescription completeness, diagnosis was documented in 86% of prescriptions, which was higher than values reported in certain previous studies, such as Shipra et al. (64.66%).[20] Proper documentation of diagnosis is crucial, as it facilitates appropriate dispensing, improves continuity of care, and reduces the likelihood of medication errors.

Dose information was recorded in 96% of prescriptions, a finding that is comparable to results reported by Shipra et al. (100%).[20] Accurate dose specification is essential for ensuring therapeutic effectiveness and minimizing adverse effects.

Despite generally satisfactory documentation practices, approximately 24% of prescriptions did not adhere to Standard Treatment Guidelines (STGs). Common deviations included inappropriate use of fixed-dose combinations, unnecessary prescription of proton pump inhibitors, and potentially irrational antibiotic combinations. Such deviations highlight the need for continuous education, reinforcement of guideline-based prescribing, and regular prescription audits.

Conclusions

Regular prescription audits, continuous medical education programs, strict adherence to Standard Treatment Guidelines, and strengthening of hospital drug and therapeutic committees may help improve prescribing practices and promote rational drug use.

Limitations

The study was conducted at a single center and involved a limited sample size of patients. Hence, the findings may not be generalizable to other healthcare settings.

Acknowledgements

We acknowledge the District Headquarter Hospital, Berhampur, Ganjam, for providing permission to enroll prescriptions and conduct this study.

Conflicts of Interest:

The authors declare that there are no conflicts of interest and no affiliations with or involvement in any organization or entity with any financial interest.



 


References


[1]    Sisay M, Mengistu G, Molla B, Amare F, Gabriel T. Evaluation of rational drug use based on World Health Organization core drug use indicators in selected public hospitals of eastern Ethiopia: a cross sectional study. BMC Health Serv Res.2017;17(1):161. doi:10.1186/s12913-017-2097-3

[2]    Rational Use of Medicines by Prescribers and Patients. Geneva: World Health Organization; 2005. Available from: http://www.apps.who. int>WHOIRIS>Headquarters>Governingbodies>EB115

[3]    WHO. World Health Organization Promoting Rational Use of Medicines: Core Components. WHO Policy and Perspectives on Medicine No. 5. Document WHO/EDM/2002.3. Geneva: WHO; 2002

[4]    Food, Medicine and Healthcare Administration and Control Authority (FMHACA) of Ethiopia. 2nd ed. Addis Ababa: Manual for Medicines Good Prescribing Practice;2012. Available from: http://www.fmhaca.gov.et/Documents/Medcines%20Good%20Prescribing%20Manual%20second%20edition%20 2012.pdf

[5]    Inform M, Mak D, Wendie TF, Ahmed A, Mohammed SA, Ghaffari F. Drug use pattern using WHO core drug use indicators in public health centers of Dessie. BMC Med Inform Decis Mak. 2021;21:1–10. doi:10.1186/s12911-021-01530-w

[6]    Kshirsagar NA. Rational use of medicines: cost consideration & way forward. Indian J Med Res. 2016;144(4):502–505. doi:10.4103/0971- 5916.200901

[7]    Ahmed B, Nanji K, Mujeeb R, Patel MJ. Effects of polypharmacy on adverse drug reactions among geriatric outpatients at a tertiary care hospital in Karachi: a prospective cohort study. PLoS One.2014;9(11):e112133.doi:10.1371/journal.pone.0112133

[8]    Kanagasabai U, Singh A, Shiraishi RW, et al. Improving injection safety practices of Cambodian healthcare workers through training. PLoS One. 2020;15(10):e0241176. doi:10.1371/journal.pone.0241176

[9]    Melku L, Wubetu M, Dessie B. Irrational drug use and its associated factors at Debre Markos referral Hospital’s outpatient pharmacy in East Gojjam, Northwest Ethiopia. SAGE Open Med. 2021;9:20503121211025144. doi:10.1177/20503121211025146

[10]    Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16(1):684. doi:10.1186/s12913-016-1932-2

[11]    WHO. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: WHO; 1993. p. 1-92.

[12]    Hazra A, Tripathi SK, Alam MS. Prescribing and dispensing activities at the health facilities of a non-governmental organization. Natl Med J India. 2000;13(4):177-82. 

[13]    13. Wang H, Li N, Zhu H, Xu S, Lu H, Feng Z. Prescription pattern and its influencing factors in Chinese county hospitals: A retrospective cross-sectional study. PLoS One. 2013;8(5):e63225. 

[14]    Bimo. Report on Nigerian field test, INRUD news. In: How to Investigate Drug Use in Health Facilities. Vol. 3. Geneva: WHO; 1992. p. 9-10.

[15]    Rehan HS, Singh C, Tripathi CD, Kela AK. Study of drug utilization pattern in dental OPD at tertiary care teaching hospital. Indian J Dent Res. 2001;12(1):51-6.

[16]    Tripathy R, Lenka B, Pradhan MR. Prescribing activities at district health care centres of Western Odisha. Int J Basic Clin Pharmacol. 2015;4:419-21.

[17]    Desalegn AA. Assessment of drug use pattern using WHO prescribing indicators at hawassa university teaching and referral hospital, South Ethiopia: A cross-sectional study. BMC Health Serv Res. 2013;13:170.

[18]    Bannenberg WJ, Forshaw CJ, Fresle D, Salami AO, Wahab HA. Evaluation of the Nile Province Essential Drug Project. Geneva: WHO; 1991.

[19]    Chandelkar UK, Rataboli PV. A study of drug prescribing pattern using WHO prescribing indicators in the state of Goa, India. Int J Basic Clin Pharmacol. 2014;3:1057-61.

[20]    Shipra J, Zafar YK, Prerna U, Kumar A. Assessment of prescription pattern in a private teaching hospital in India. Int J Pharm Sci. 2013;3(3):219-22.
 


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications